Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Headache | 2 | 2024 | 151 | 1.490 |
Why?
|
| Terminology as Topic | 1 | 2024 | 257 | 0.740 |
Why?
|
| Transgender Persons | 2 | 2023 | 210 | 0.730 |
Why?
|
| Headache Disorders, Primary | 1 | 2021 | 4 | 0.690 |
Why?
|
| Headache Disorders, Secondary | 1 | 2021 | 4 | 0.690 |
Why?
|
| Biomedical Research | 2 | 2024 | 717 | 0.640 |
Why?
|
| Hormone Replacement Therapy | 1 | 2021 | 107 | 0.630 |
Why?
|
| Sexual and Gender Minorities | 2 | 2021 | 259 | 0.630 |
Why?
|
| White Matter | 2 | 2020 | 153 | 0.630 |
Why?
|
| Drug Interactions | 1 | 2021 | 405 | 0.610 |
Why?
|
| Artificial Intelligence | 1 | 2024 | 381 | 0.610 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 1 | 2020 | 50 | 0.600 |
Why?
|
| Brain Diseases | 1 | 2020 | 155 | 0.570 |
Why?
|
| Machine Learning | 1 | 2024 | 587 | 0.570 |
Why?
|
| Cytomegalovirus Infections | 1 | 2020 | 206 | 0.540 |
Why?
|
| Hearing Loss | 1 | 2020 | 249 | 0.480 |
Why?
|
| Practice Guidelines as Topic | 2 | 2021 | 1581 | 0.480 |
Why?
|
| Neurology | 3 | 2023 | 116 | 0.460 |
Why?
|
| Headache Disorders | 2 | 2024 | 19 | 0.380 |
Why?
|
| Brain | 2 | 2023 | 2947 | 0.360 |
Why?
|
| Testosterone | 2 | 2023 | 416 | 0.210 |
Why?
|
| Sertraline | 2 | 2013 | 27 | 0.190 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2023 | 3904 | 0.180 |
Why?
|
| Brain Mapping | 2 | 2023 | 538 | 0.170 |
Why?
|
| Estrogens | 1 | 2023 | 367 | 0.160 |
Why?
|
| Migraine Disorders | 1 | 2021 | 114 | 0.150 |
Why?
|
| Neuroimaging | 2 | 2020 | 297 | 0.150 |
Why?
|
| Hearing Tests | 1 | 2020 | 53 | 0.150 |
Why?
|
| Sex Distribution | 1 | 2020 | 387 | 0.150 |
Why?
|
| Transition to Adult Care | 1 | 2020 | 103 | 0.140 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2020 | 115 | 0.140 |
Why?
|
| Neonatal Screening | 1 | 2020 | 179 | 0.140 |
Why?
|
| Research Personnel | 1 | 2020 | 184 | 0.140 |
Why?
|
| Career Choice | 1 | 2020 | 234 | 0.130 |
Why?
|
| Cerebral Cortex | 2 | 2012 | 473 | 0.130 |
Why?
|
| Case-Control Studies | 2 | 2023 | 3623 | 0.120 |
Why?
|
| Humans | 13 | 2024 | 145474 | 0.120 |
Why?
|
| Prevalence | 1 | 2023 | 2865 | 0.120 |
Why?
|
| Sex Characteristics | 2 | 2012 | 782 | 0.110 |
Why?
|
| Longitudinal Studies | 1 | 2023 | 2953 | 0.110 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 3413 | 0.110 |
Why?
|
| Antidepressive Agents | 2 | 2013 | 242 | 0.100 |
Why?
|
| Retrospective Studies | 2 | 2023 | 17291 | 0.100 |
Why?
|
| Gyrus Cinguli | 1 | 2013 | 97 | 0.090 |
Why?
|
| Puberty | 2 | 2012 | 137 | 0.090 |
Why?
|
| Mental Disorders | 1 | 2021 | 1163 | 0.090 |
Why?
|
| Gray Matter | 1 | 2013 | 92 | 0.090 |
Why?
|
| Personality Inventory | 1 | 2012 | 134 | 0.090 |
Why?
|
| Pediatrics | 1 | 2020 | 1121 | 0.090 |
Why?
|
| Prospective Studies | 2 | 2023 | 8057 | 0.090 |
Why?
|
| Sexual Maturation | 1 | 2012 | 48 | 0.090 |
Why?
|
| Temporal Lobe | 1 | 2012 | 105 | 0.090 |
Why?
|
| Male | 8 | 2023 | 72842 | 0.080 |
Why?
|
| Adolescent | 4 | 2023 | 22529 | 0.070 |
Why?
|
| Female | 7 | 2023 | 78844 | 0.070 |
Why?
|
| Child | 4 | 2023 | 22707 | 0.070 |
Why?
|
| Infant, Newborn | 1 | 2020 | 6447 | 0.070 |
Why?
|
| Infant | 1 | 2020 | 10077 | 0.060 |
Why?
|
| Adult | 2 | 2023 | 40777 | 0.040 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2012 | 288 | 0.040 |
Why?
|
| Social Stigma | 1 | 2021 | 172 | 0.040 |
Why?
|
| Consensus | 1 | 2020 | 477 | 0.030 |
Why?
|
| Neuropsychological Tests | 2 | 2013 | 1134 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2020 | 899 | 0.030 |
Why?
|
| Burnout, Professional | 1 | 2020 | 488 | 0.020 |
Why?
|
| Parahippocampal Gyrus | 1 | 2012 | 11 | 0.020 |
Why?
|
| Hypertrophy | 1 | 2013 | 128 | 0.020 |
Why?
|
| Caudate Nucleus | 1 | 2012 | 22 | 0.020 |
Why?
|
| Organ Size | 1 | 2012 | 461 | 0.020 |
Why?
|
| Frontal Lobe | 1 | 2012 | 160 | 0.020 |
Why?
|
| Age of Onset | 1 | 2013 | 555 | 0.020 |
Why?
|
| Amygdala | 1 | 2012 | 199 | 0.020 |
Why?
|
| Neural Pathways | 1 | 2012 | 313 | 0.020 |
Why?
|
| Reaction Time | 1 | 2012 | 433 | 0.020 |
Why?
|
| Psychometrics | 1 | 2012 | 731 | 0.020 |
Why?
|
| Cognition Disorders | 1 | 2012 | 541 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2013 | 11772 | 0.020 |
Why?
|
| Hippocampus | 1 | 2012 | 971 | 0.020 |
Why?
|
| Sex Factors | 1 | 2012 | 2105 | 0.010 |
Why?
|
| Age Factors | 1 | 2012 | 3342 | 0.010 |
Why?
|
| Young Adult | 1 | 2020 | 14218 | 0.010 |
Why?
|
| Aged | 2 | 2013 | 26153 | 0.010 |
Why?
|
| Middle Aged | 1 | 2012 | 36215 | 0.000 |
Why?
|